Goat Polyclonal POLG antibody. Suitable for ELISA, WB and reacts with Hepatitis C virus samples. Cited in 1 publication.
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS
ELISA | WB | |
---|---|---|
Hepatitis C virus | Tested | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Hepatitis C virus | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Hepatitis C virus | Dilution info Use at an assay dependent concentration. | Notes - |
Core protein, E1 protein, E2 protein, Envelope glycoprotein E2, HCV E2, NS2 protein, NS3 protease/helicase, NS4A protein, NS4B protein, NS5A protein, NS5B RNA-dependent RNA polymerase, P7 protein, Polyprotein, gp68, gp70
Goat Polyclonal POLG antibody. Suitable for ELISA, WB and reacts with Hepatitis C virus samples. Cited in 1 publication.
Preservative: 0.1% Sodium azide
Constituents: 0.0268% PBS
>95% pure. Sodium sulfate precipitation and ion-exchange chromatography.
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
The Hepatitis C virus (HCV) envelope protein E2 sometimes called HCV E2 glycoprotein plays a mechanical role in viral entry into host cells. This protein forms part of the viral envelope which is expressed on the surface of the hepatitis C virus. HCV E2 is about 70 kilodaltons in mass and interacts with specific host cell receptors to mediate viral attachment and entry. It is important in establishing infection as it facilitates the fusion of the viral and host cell membranes.
The hepatitis C virus E2 glycoprotein interacts with host cell receptors such as CD81 and scavenger receptor class B type 1 (SR-B1). These interactions are necessary for virus entry and infectivity. It does not function alone but as part of a larger complex working alongside the E1 protein to mediate these processes. By forming a heterodimer with E1 the E2 protein ensures proper folding structural stability and efficient functioning within the viral lifecycle.
The envelope E2 protein plays a critical role in the viral entry pathway. It is an essential component of the pathway that involves initial attachment to the host cell surface. This step is followed by engagement with co-receptors and endocytosis. Proteins associated with this process include CD81 which is pivotal in facilitating the entry of HCV into hepatocytes. E2's interaction with host factors like SR-B1 further exemplifies its central role in the viral lifecycle.
Hepatitis C virus E2 is linked to hepatitis C infection which can progress to chronic liver disease and cirrhosis. Its interaction with the CD81 receptor is important for the virus's ability to infect liver cells making it a target for therapies designed to block viral entry. Chronic infection with hepatitis C is also associated with hepatocellular carcinoma with E2 likely contributing to oncogenic processes through its interactions with host cellular pathways.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ELISA analysis of Hepatitis C Virus E2 binding to CD81 receptor, using ab20044 to detect Hepatitis C Virus E2 binding.
A 96-well plate was coated with 100 ng of rho-1D4 antibody. Following overnight incubation at 4°C, the unbound antibody was washed away. The wells were blocked with blocking solution for 2 hours. 100 ng of purified CD81 was added to the wells along with E2 glycoprotein (0.4 to 20 nM) and incubated for 2 hours. ab20044 anti-Hepatitis C Virus E2 antibody (1/2000 dilution) and secondary antibody with alkaline phosphatase conjugate (1/1000 dilution) were added and incubated for 2 hours. Absorbance was measured at 495 nm by a plate-reader.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com